Financials
- Market Capitalization 15.37 M
- Employee 18
- Founded 2017
- CEO N/A
- Website vyometx.com
- Headquarter Delaware, United States
- FIGI BBG0036S6JY0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.71
Fiyat/satışlar oranı
23.26
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4697 | CYCN Cyclerion Therapeutics, Inc. - Common Stock | 3.71 USD | -4.38% | +9.76% | +12.08% | +14.15% | 16.07 M USD | ||
| 4704 | AKTX Akari Therapeutics Plc - American Depositary Shares | 13.61 USD | +1.57% | -8.60% | +1.19% | +1126.13% | 15.58 M USD | ||
| 4711 | QNCX Quince Therapeutics, Inc. - Common Stock | 18.73 USD | +8.58% | +12.63% | +1913.98% | +934.81% | 15.27 M USD | ||
| 4722 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | 0.00% | +11.32% | -1.67% | -29.76% | 14.62 M USD |